Slide 4. Slide 5. Slide 6
|
|
- Vincent Hodge
- 6 years ago
- Views:
Transcription
1 Slide 1 Slide 4 Allergic Response Mechanisms of Type 1 hypersensitivity allergic reaction, IgE-mediated mast cell degranulation, and release of inflammatory mediators Antigen Derek N. Cunningham, O.D., FAAO derek.n.cunningham@gmail.com Antigen Antigen Release of Mediators Antigen-Presenting Capillary Cell Mast Cell Epithelium IgE Activation Production Antigen IgE Mediators Capillary Clinical Presentation Effects/ Lumen Ca ++ Rises Signs and Symptoms TH2 IL-4, IL-13 B Cell Cell IFNy IL-3, IL-4 IL-4 IL-5 IL-6 GM-CSF TNF-α IL-8 IL-9 Inflammatory Cell Activation Adapted with permission from Ghaffar A. Hypersensitivity Reactions. In: Microbiology and Immunology On-Line. University of South Carolina School of Medicine Web Site. Available at: Accessed February 7, Slide 2 Slide 5 Components of an Allergic Response T helper cells (Type-1 and Type-2) Mast Cells Histamine Eosinophils Neutrophils Cytokines Adhesion Molecules Slide 3 Treatment vs Management Slide 6 Early- and Late-Phase Inflammatory Mediators Early-Phase Mediators Mast Cell Membrane Phospholipids Late-Phase Mediators Phospholipase A 2 Activity Arachidonic Acid Histamine Heparin Proteases (tryptase, chymase) PAF Cyclo-oxygenase Pathway Lipoxygenase Pathway Cyclic Endoperoxides Hydroperoxides (5-HPETE) Prostaglandins Prostacyclin Thromboxane A 2 (PGF 2α, PGD 2, PGE 2) (PGI 2) (TXA 2) Adapted with permission from Donnenfeld ED. Refract Eyecare. 2005;9(suppl): Slonim CB. Rev Ophthalmol. 2000: HHT, MDA Leukotrienes (LTC 4, LTD 4, LTE 4, LTB 4)
2 Slide 7 Eosinophils Main Characters Slide 10 Neutrophils Cytokines Adhesion Molecules Slide 8 Secondary Mediators Slide 11 PRIMING Leukotrienes - vascular permeability, sm contraction Prostaglandins - vasodilation, sm contraction, platelet activation Bradykinin - vascular permeability, sm contraction Cytokines - numerous effects incl. activation of vascular endothelium, eosinophil recruitment and activation In allergy there is an up-regulation of the receptors on the epithelial surface that bind eosinophils and neutrophils. Slide 9 Secondary/Late phase mediators Slide 12 Common Factor Responsible for development of severe disease Carry the risk of scarring Are self perpetuating All allergic conditions itch. All allergy involves mast cell activation Release inflammatory mediators Recruit inflammatory cells
3 Slide 13 Seasonal Allergic Conjunctivitis Slide 16 Early-Phase Reactions Definition: Common, recurrent, bilateral ocular inflammatory process often initiated by airborne allergens 1 Manifested by mild to severe symptoms of ocular discomfort 1,2 Mast cell: common denominator in all types of ocular allergies 1,3 Type I immediate-ige hypersensitivity allergic reaction 1,4 Pathogenesis involves a complex interactive mechanism between IgE-mediated mast cell degranulation and the release of inflammatory mediators 1 Occurs approximately 20 minutes after the initial antigen challenge and persists for 1-2 hours 3,4 Mast cell degranulation marks the beginning of the acute early-phase reaction 1,2 Histamine is released along with cytokines and other preformed mediators 1,2 These events elicit the immediate signs and symptoms of the ocular allergic reaction 1,2 The duration of these signs and symptoms in the acute, early phase of the allergic reaction is correlated with their intensity 2 1. Bhargava A et al. Drugs Today. 1998;34: Shulman DG et al. Ophthalmology. 1999;106: Abelson MB et al. Ocul Surf. 2003;1: Bonini S, Ghinelli E. Acta Ophthalmol Scand. 2000;78: Bhargava A et al. Drugs Today. 1998;34: Abelson MB et al. Ocul Surf. 2003;1: Nichols KK et al. Optometric Mgmt April Bielory L et al. Medscape Gen Med 2007; 9(3):35 Slide 14 Pathophysiology of Seasonal Allergic Conjunctivitis: Chemical Mediators 1-3 Slide 17 We need an Antihistamine Generated through the inflammatory cascade Play a key role in the inflammatory reaction of the ocular allergic response Created through the cascade as Early-phase chemical mediators (preformed) Late-phase chemical mediators (newly formed) King of the allergy treatments Proven safety for long term use Instant relief 1. Slonim CB, Boone S. Formulary. 2004;39: Slonim CB. Rev Ophthalmol. 2000: Bhargava A et al. Drugs Today. 1998;34: Slide 15 Mast Cell Slide 18 Side Effects Primary cellular component of the ocular allergic reaction 1 Main source of early, preformed inflammatory mediators and a variety of cytokines 1 Mediators and cytokines are responsible for the initiation and progression of the allergic inflammatory reaction, respectively 2 Cytokines play a central role in the immunoregulatory mechanism of the ocular allergic response 3 1. Abelson MB et al. Ocul Surf. 2003;1: Slonim CB. Rev Ophthalmol. 2000: Bhargava A, et al. Drugs Today. 1998;34:
4 Slide 19 Late-Phase Reactions Slide 22 Corticosteroids Clinical and histopathological phenomenon characterized by the release of newly formed mediators and the recruitment of inflammatory cells 1,2 Causes further tissue damage 2 Continues the inflammatory cycle 3 Occur 4 to 8 hours after the initial antigen challenge, and persists for up to 24 hours 1 Dependent on the initial antigen dose 2 Clinically characterized by the persistence of signs and symptoms 2 The time course for the development of these signs and symptoms has been well established 2 Will control prostaglandins and leukotrienes STOPS THE INFLAMMATION CASCADE Suppresses inflammation Allows for reestablishment of the neural feed back loop 1. Bonini S et al. Acta Ophthalmol Scand. 2000;78(suppl 230): Abelson MB et al. Ocul Surf. 2003;1: Donnenfeld ED. Refract Eyecare. 2005;9: Slide 20 We need something more Slide 23 Conjunctival Time Course of Selected Inflammatory Cells and Mediators The complete system complex is more than histamine. It has peaks and troughs well beyond the acute stage, therefore all of these mediators need to be treated when treating allergies Late phase mediators 120 can occur as early as 6 hours after initial antigen 90 challenge Median Values Time (hour) Histamine Leukotrienes Tryptase Neutrophils Eosinophils ICAM-1 Adapted from L Bielory, MD for UMDNJ - New Jersey Medical School UMDNJ - Center for Continuing and Outreach Education. Diagnosis and Management of Ocular Allergy: Update. CME-Certified slide kit on CD-ROM. Release date Nov 15, Slide 21 Corticosteroids Slide 24 All Early- and Late-Phase Mediators Should be used whenever the eye looks inflammatory Decreased tear production and tear clearance lead to chronic inflammation (and lid friction) on the ocular surface Are often needed to prevent corneal involvement Should be used in a pulse regime 1. Slonim CB. Rev Ophthalmol. 2000: Slonim CB, Boone R. Formulary. 2004;39: Nichols KK, Morris S, Weibel KA. Get the reaction you want. Optometric Management. April Available at: Accessed January 9, Bielory L, Katelaris CH, Lightman S, Naclerio RM. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. Medscape Gen Med. 2007;9(3):35. Available at: Accessed January 28, 2008.
5 Slide 25 Late-Phase Review Slide 28 Leukotriene and IL-5 Eosinophils, and other mediators are recruited Denburg JA, Ed.; Allergy and Allergic Diseases: The New Mechanisms and Therapeutics; Humana Press; ISTA Pharmaceuticals, Inc. All rights reserved. OPH BRV910-3/11 Slide 26 Functions of other Immune Cells Slide 29 Seasonal Conjunctivitis Tear film Conjunctiva Cornea is almost never involved Few Papillae Often itches more than it would appear Stroma Lots of symptoms and little to no signs Eosinophils release a variety of toxic proteins that can damage the conjunctival epithelium Denburg JA, Ed.; Allergy and Allergic Diseases: The New Mechanisms and Therapeutics; Humana Press; ISTA Pharmaceuticals, Inc. All rights reserved. OPH BRV910-3/11 Slide 27 NSAIDS Slide 30 QD for Allergy? Reduce itching as well as burning and itching Patients with multiple symptoms may benefit
6 Slide 31 Perennial Conjunctivitis Slide 34 Modalities for treating itching associated with Allergic Conjunctivitis 1 Symptoms persist past allergy season May be atopic, with an immune dysregulation Benefit from allergist consult Allergen Avoidance Rx Mast Cell Stabilizers Lubrication/ Cool Compresses Artificial Tears Rx Topical Corticosteroids OTC topical antihistamines, vasoconstrictors Rx NSAIDs Rx Dual-Action Antihistamine/Mast Cell Stabilizers BEPREVE Indicated for the treatment of itching associated with allergic conjunctivitis Slide 32 Atopic Conjunctivitis Threat EVERY EFFORT MUST BE MADE TO CONTROL THE DISEASE BEFORE THE CORNEAL CHANGES OCCUR Slide 35 Treating seems easy. How do we Manage? Watch for constellation of conjunctivitis, rhinitis, asthma, eczema Slide 33 Why do we fail? Slide 36 Artificial tears are necessary Tear Substitutes: Barrier function - improve 1st line of defense; Dilute allergens and mediators in tears; Flush allergens and mediators out of the eye; Non-preserved are preferred; Keep refrigerated for added comfort
7 Slide 37 Mast cell stabilization Slide 40 Co-morbidities Stabilization of mast cells can not take place in the presence of edema or inflammation. The receptors are bound by other factors and the mast cell stabilizers have a decreased ability to get to the binding site. Allergy Dry Eye Lid disease Inflammation Slide 38 Mast cell stabilization in the presence of inflammation Slide 41 HOT TEARS? 38 Slide 39 Slide 42 DRY EYE
8 Slide 43 Create a Barrier Slide 46 Thiazide Diuretics Tear film is the best barrier When to prescribe artificial tears 43 Slide 44 Limit Exposure Slide 47 Which one comes first? Slide 45 What is the main function of the tear film? Slide 48 Dry Eye Treatments Lubricate Nourish Anti-microbial Clean the surface Transport oxygen Acts as a barrier Optical surface Treatment vs Management
9 Slide 49 The Asclepius Panel Recommended Treatment Model for Dry Eye Inflammation Slide 52 High prevalence of bleph possibly due to poor diet Thereafter Lotemax QID (loteprednol etabonate ophthalmic suspension 0.5%) Lotemax BID (loteprednol etabonate ophthalmic suspension 0.5%) Lotemax up to QID for flare-ups (loteprednol etabonate ophthalmic suspension 0.5%) Restasis BID (cyclosporine ophthalmic emulsion) 0.05%) Artificial Tears Adapted from Holland EJ. Ophthalmol Times. 2007;32:3-11. Slide 50 Antihistamines causing dry eye Slide 53 Patients may not be well educated on nutrition 53 Slide 51 Blepharitis Not Easy Slide 54 Blepharitis Chronic Uncertain etiology Coexisting ocular disease Itchy eyelids!!!!! Constantly releases inflammatory factors into the tear film Tear film then provides vehicle to bath all tissues in these inflammatory factors Lack of proper tear film allows extended contact time between factor and tissue
10 Slide 55 Culprits Slide 58 Antibiotics? Staphylococcus epidermidis S. aureus Toxin production Cell mediated immunity Staph antigens cause inflammation Tetracycline analogues have been shown to decrease bacterial lipases, and demonstrate anti-inflammatory properties in the cornea Should be used with moderate bleph or MGD, and when corneal involvement is significant Doxy mg/day x 30 days (may need a maintenance dose of 100mg x up to 6 months) Use Minocycline if tolerability is an issue, or increased sun exposure Slide 56 Bleph Treatments? Slide 59 Doxy Are warm compresses and lid scrubs necessary? Artificial tears Antibiotics Oral or topical? What about the inflammation? Doxycycline--a role in ocular surface repair Br. J. Ophthalmol., May 1, 2004; 88(5): Doxycycline irreversibly inhibits corneal MMP- 2 activity by chelating the metal ions that are catalytically and structurally essential. Slide 57 Antibiotics Slide 60 Omega-3 Topical Bacitracin Great for the bacteria, not so much for the inflammation Combos Zylet and Tobradex Tobramycin Women Health Study Harvard School of Public Health Consumption of Omega-3s was directly related to a decreased risk of dry eye Omega-6 counteracts benefits of Omega-3 Consumption of Omega-6s was correlated with increased risk of dry eye
11 Slide 61 Omega-3 Slide 64 Slide 62 How can we make our lives more difficult? Slide 65 Slide 63 GPC Slide 66 All Early- and Late-Phase Mediators 1. Slonim CB. Rev Ophthalmol. 2000: Slonim CB, Boone R. Formulary. 2004;39: Nichols KK, Morris S, Weibel KA. Get the reaction you want. Optometric Management. April Available at: Accessed January 9, Bielory L, Katelaris CH, Lightman S, Naclerio RM. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. Medscape Gen Med. 2007;9(3):35. Available at: Accessed January 28, 2008.
12 Slide 67 NSAIDS with contacts? Slide 68 THANK YOU Thank you
Provided as a service by CiplaMed
Allergy Reaction of the body tissues to an allergen which leads to production of antibodies finally culminating in an antigen-antibody antibody reaction. Normal Individual Entry of allergen Allergen-Antibody
More informationOcular Allergies: Scratching the Surface. -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms
How Many People Are Affected? Ocular Allergies: Scratching the Surface Mile Brujic, OD -20%-50% of the population has allergies -83% of allergy sufferers experience ocular symptoms Disclosure: I have no
More informationImpact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma
American Association for Respiratory Care Asthma Educator Certification Prep Course Asthma Epidemiology and Pathophysiology Robert C. Cohn, MD, FAARC MetroHealth Medical Center Cleveland, OH Impact of
More informationOcular allergy pathogenesis and diagnosis
Ocular allergy pathogenesis and diagnosis Luís Delgado, MD PhD departament of Immunology and Immunoallergology Unit Hospital de S. Joao. Porto (Portugal) Marzo 2006 www.alergomurcia.com Good morning, Mr.
More informationOphthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management Branch
May 2017 Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers Executive Summary Page 1 of 5 Ophthalmic-1s: Antihistamine and Dual Acting Antihistamine/Mast Cell Stabilizers DHA Formulary Management
More informationOphthalmic Antihistamine Step Therapy Program Summary
Ophthalmic Antihistamine Step Therapy Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-8 Drug FDA Indication(s) Administration and Dosing Bepreve Treatment of itching associated Instill one drop into
More informationImplications on therapy. Prof. of Medicine and Allergy Faculty of Medicine, Cairo University
Implications on therapy Dr. Hisham Tarraf MD,FRCP(Edinb.) Prof. of Medicine and Allergy Faculty of Medicine, Cairo University Need for better understanding Global health problem Impact on quality of life
More informationAllergic rhinitis (Hay fever) Asthma Anaphylaxis Urticaria Atopic dermatitis
Hypersensitivity Disorders Hypersensitivity Disorders Immune Response IgE Disease Example Ragweed hay fever IgG Cytotoxic Immune complex T Cell Hemolytic anemia Serum sickness Poison ivy IgE-mediated Diseases
More information12/3/2011. Disclosure. Allergic Eye Disease: Diagnostic Pearls and Treatment Options. Symptoms. Allergy Eye Disease
Disclosure Allergic Eye Disease: Diagnostic Pearls and Treatment Options I have no financial relationships to disclose. Ophthalmology Update 2011 Matilda Chan MD, PhD Department of Ophthalmology, UCSF
More informationHypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host.
Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host. Hypersensitivity vs. allergy Hypersensitivity reactions require a pre-sensitized
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
More informationConjunctivitis - Allergic, Seasonal & Perennial (1 of 6) Patient presents w/ symptoms suggestive of allergic conjunctivitis
, Seasonal & Perennial ( of 6) A B Patient presents w/ symptoms suggestive of allergic conjunctivitis Non-pharmacological therapy 2 DIAGNOSIS Does the clinical presentation confirm seasonal or perennial
More informationThe allergic diseases that affect
TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS Jimmy D. Bartlett, OD, DSc Allergic conjunctivitis affects approximately 15% of the global population and has a higher prevalence of about 40% in industrialized
More informationImmunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline Consensus characteristics/incidence data Immune/inflammatory basis Etiology/Genetic basis Hygiene
More informationDr Rachael Neiderer. Ophthalmologist Auckland. 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out
Dr Rachael Neiderer Ophthalmologist Auckland 8:35-8:50 Managing Allergic Conjunctivitis & Why Sodium Chromoglycate is Out Allergic conjunctivitis Rachael Niederer Greenlane Clinical Centre, Auckland Case
More informationCondition: Allergic Eye Disease (Type 1 Hypersensitivity reactions)
Condition: Allergic Eye Disease (Type 1 Hypersensitivity reactions) Description: Seasonal allergic conjunctivitis is caused by seasonal allergens, especially grass pollen, whereas perennial conjunctivitis
More informationDEWS Severity Analysis 11/30/12. Blephari/s, MGD and Ocular Surface Disease. Ben Gaddie, O.D., F.A.A.O. Louisville, KY
Blephari/s, MGD and Ocular Surface Disease Ben Gaddie, O.D., F.A.A.O. Louisville, KY Advisory Board of Inspire, Allergan, Pfizer, Bausch & Lomb, Zeiss Humphrey, OcusoK Speakers Bureau of Alcon, VSP, Allergan,
More informationOCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY
OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY SURFACE DISEASE DRY EYE DYSFUNCTIONAL TEARS SYND ALLERGIC DISORDERS MEIBOMIAN GLAND PROBLEMS OCULAR IMMUNE
More informationOphthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary
Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)
More informationOCULAR ALLERGY IN CHILDREN. Presenter: Dr C.L.A Ogundo Consultant Ophthalmologist KPA conference April 2017
OCULAR ALLERGY IN CHILDREN Presenter: Dr C.L.A Ogundo Consultant Ophthalmologist KPA conference April 2017 Introduction Hypersensitivity disorder Conjunctival surface is accessible to allergens and is
More informationThe Emergent Eye in the Acute Setting
The Emergent Eye in the Acute Setting Todd P. Margolis MD, PhD Professor of Ophthalmology & Director of the F.I. Proctor Foundation UCSF Physical Exam-- Visual Acuity Essential Corrected visual acuity
More informationMast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?
Urticaria: What happens in the skin? Updates on Chronic Urticaria Kent Woo, MD (USA) Allergy/Immunology Internal Medicine C A U S E MC, mast cell IgE Fc eri MC Release of Mediators Activation Vasodilation
More informationPeople with eye allergies typically have symptoms that include: Eye Anatomy: What Do Eye Allergies Actually Effect?
Eye Allergies Eye Allergies People with eye allergies typically have symptoms that include: Itchy watery eyes Eyelid problems Dark circles around eyes Dry eyes Reactions to Contacts Let us help allow you
More informationAttribution: University of Michigan Medical School, Department of Microbiology and Immunology
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution
More informationNew Ways to Ease Allergy Symptoms
New Ways to Ease Allergy Symptoms New pharmacologic and immunotherapeutic agents may offer options for allergy sufferers. Michelle Stephenson, Contributing Editor 3/8/2012 Allergy season is quickly approaching,
More informationINFLAMMATION & REPAIR
INFLAMMATION & REPAIR Lecture 7 Chemical Mediators of Inflammation Winter 2013 Chelsea Martin Special thanks to Drs. Hanna and Forzan Course Outline i. Inflammation: Introduction and generalities (lecture
More informationInnate vs Adaptive Response
General Immunology Innate vs Adaptive Response Innate- non-specific (4 types of barriers) anatomic- ato mechanical ca (skin), ph, mucous, normal flora Physiologic- temperature, ph, chemicals (lysozyme,
More informationNORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: TABLE OF CONTENTS
NORTHEAST OHIO NEIGHBORHOOD HEALTH SERVICES, INC. OPTOMETRIC MEDICINE CLINICAL GUIDELINES: 2012-2013 TABLE OF CONTENTS CONDITION PAGE(S) Complete Eye and Vision Examination 2 Vision Screening Procedure
More informationItchy eyes a little irritation or a big pain
Itchy eyes a little irritation or a big pain Mrs Melanie Hingorani Consultant Ophthalmologist Moorfields Eye Hospital Declaration of any conflicts of interest None Allergic Eye Disease Group of disorders
More informationGrow Your Practice With a Focus on Ocular Allergy
By Scot Morris, O.D., F.A.A.O. Grow Your Practice With a Focus on Ocular Allergy Build your allergy patient base by making accurate diagnoses, offering the best treatments and increasing revenues with
More information1) Mononuclear phagocytes : 2) Regarding acute inflammation : 3) The epithelioid cells of follicular granulomas are :
Pathology Second 1) Mononuclear phagocytes : - Are the predominant cells in three day old wounds - Are common in liver, spleen and pancreasd - Produce fibroblast growth factor - Secrete interferon-g -
More informationDo You Want Steroids with THAT?! Bruce Onofrey, OD, RPh, FAAO
Do You Want Steroids with THAT?! Bruce Onofrey, OD, RPh, FAAO Disclosure Statement: Nothing to disclose Please remember to complete your session evaluations on the Academy.18 meeting app Tweet about this
More informationOcular allergy: implications for the clinical immunologist C. H. Katelaris, MD, PhD
Ocular allergy: implications for the clinical immunologist C. H. Katelaris, MD, PhD Background: Allergic diseases of the eye are the most common conditions affecting the external ocular adnexa. The most
More informationAllergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital
Allergy overview Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Adaptive Immune Responses Adaptive immune responses allow responses against
More informationComments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications
Comments: Even though OTC vasoconstrictors and antihistamines are popular, a recent article suggests that these drugs can cause rebound dilation of conjunctival vessels Chronic Drug Treatments Mast Cell
More informationHYPERSENSITIVITY REACTIONS D R S H O AI B R AZ A
HYPERSENSITIVITY REACTIONS D R S H O AI B R AZ A HYPERSENSITIVITY REACTIONS Are exaggerated immune response upon antigenic stimulation Individuals who have been previously exposed to an antigen are said
More informationSeasonal Allergic Rhinoconjunctivitis
Seasonal Allergic Rhinoconjunctivitis Allergic rhinoconjunctivitis is a common condition. Most patients can achieve good symptom control through allergen avoidance and pharmacotherapy with non-sedating
More informationTitle: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD
Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Course Description: The Dry Eye Workshop 2 was an assemblage of experts in dry eye disease from around the world,
More informationMEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?
MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? Alan G. Kabat, OD, FAAO (901) 252-3691 Memphis, Tennessee alan.kabat@alankabat.com Course description: This course reviews the latest thoughts,
More informationCell-Derived Inflammatory Mediators
Cell-Derived Inflammatory Mediators Introduction about chemical mediators in inflammation Mediators may be Cellular mediators cell-produced or cell-secreted derived from circulating inactive precursors,
More informationAllergic Conjunctivitis
Allergic Conjunctivitis ASCIA EDUCATION RESOURCES (AER) PATIENT INFORMATION Allergic conjunctivitis usually causes mild to moderate symptoms, including redness, which respond to non medicated treatment.
More informationSporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms
Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms Massimo Triggiani, MD, PhD Division of Allergy and Clinical Immunology University of Salerno HAWK Consensus Meeting Gargnano,
More informationDr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline
Pathology of Asthma Dr Rodney Itaki Lecturer Division of Pathology Anatomical Pathology Discipline Bronchial Asthma Definition: chronic, relapsing inflammatory lung disorder characterised by reversible
More informationKetotifen Fumarate and Olopatadine Hydrochloride in the Treatment of Allergic Conjunctivitis: A Real-World Comparison of Efficacy and Ocular Comfort
Advances In Therapy Volume 20 No. 2 March/April 2003 Ketotifen Fumarate and Olopatadine Hydrochloride in the Treatment of Allergic Conjunctivitis: A Real-World Comparison of Efficacy and Ocular Comfort
More informationOphthalmology Times Case Study Yasmin Mali, MD. Case Study
Ophthalmology Times Case Study Yasmin Mali, MD Case Study A 57 year old female with presented with ocular irritation and discomfort in both eyes for several months. Patient was previously started on a
More informationOcular Allergy. Phil Lieberman, MD
Ocular Allergy Phil Lieberman, MD Disclosure Consultant/Advisory Board: Genentech, Meda, Mylan, Teva Speaker: Genentech, Meda, Merck, Mylan, Teva Learning Objectives Upon completion of this session, participants
More informationOverview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...
Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... This Allergan sponsored session was held on July 24, 2005, Hotel Satya Ashoka, Jabalpur. The session was followed
More informationOral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children
Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children Daniel S. Choi, BA, and Ali Djalilian, MD Author affiliations: Department of
More informationPAINFUL PAINLESS Contact lens user BOV
Common Causes Allergies Infections Ocular Cornea, uveitis, endophthalmitis Orbital Orbital cellulitis Inflammation Uveitis Scleritis / episcleritis Glaucomas Trauma Foreign bodies Chemical injuries History
More informationUnderstanding and managing allergic conjunctivitis
Understanding and managing allergic conjunctivitis Mile Brujic, OD Ocular allergies are one of the most common conditions that doctors of optometry will treat in our practices. Although the prevalence
More informationPredisposing factors. Gender. Ocular Surface Disease. Ocular Surface Disease Health. Building a Dry Eye Practice
Ocular Surface Disease Health Building a Dry Eye Practice Paul M. Karpecki, OD, FAAO Koffler Vision Group Lexington, KY Discuss the associated pathology of dry eye Discuss modalities of diagnosis, etiology
More informationSepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital
Sepideh Tara Rousta, MD FAAO Robert Wood Johnson University Hospital Saint Peter s University Hospital Wills Eye Hospital 14 mo old w R eye cross (parents) 9 mo old R eye crossing getting worse for past
More informationImmunologic Mechanisms of Tissue Damage. (Immuopathology)
Immunologic Mechanisms of Tissue Damage (Immuopathology) Immunopathology Exaggerated immune response may lead to different forms of tissue damage 1) An overactive immune response: produce more damage than
More informationand its clinical implications
The Immunology of Allergy and its clinical implications By Dr Priya Bowry Sikand MBBS MRCGP DFFP DIC MSc(Allergy) Back to the Basics. Objectives Understand immunological mechanisms behind Type 1 Hypersensitivity
More informationHerpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry
Herpetic Eye Disease Jason Duncan, OD, FAAO Diplomate, American Board of Optometry Associate Professor, Southern College of Optometry I have what?! How to break the news Meet the Herpes Quick virology
More informationOptimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC
Optimizing the Ocular Surface Presentation Title Presenter Charlene M. Grice, Name MD Carolina Eyecare Physicians, LLC Financial Disclosures I have no financial disclosures. I will discuss off label use
More informationThe Skinny of the Immune System
The Skinny of the Immune System Robert Hostoffer, DO, FACOP, FAAP Associate Professor of Pediatrics Case Western Reserve University, Cleveland, Ohio Overview 1. Immune system of the skin 2. Immune Players
More informationCLINICAL SCIENCES. Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model
CLINICAL SCIENCES Efficacy of Ketotifen Fumarate 0.025% Ophthalmic Solution Compared With Placebo in the Conjunctival Allergen Challenge Model Mark B. Abelson, MD; Matthew J. Chapin, BS; Barry M. Kapik,
More informationAllergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children
The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and
More informationAnaphylaxis: The Atypical Varieties
Anaphylaxis: The Atypical Varieties John Johnson, D.O., PGY-4 Allergy/Immunology Fellow University Hospitals of Cleveland Case Western Reserve University School of Medicine Disclosures: None What is Anaphylaxis?
More informationDISCLOSURES. PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD HISTORY, HISTORY, HISTORY WHY RED EYES? EXAMINE THE EYE RED FLAGS TO REFER 3/25/2019
DISCLOSURES Consultant/Speakers bureaus Research funding PEDIATRIC RED EYES Rachel M. Smith, OD, FCOVD Pediatric Optometrist Children s Hospital & Medical Center Stock ownership/corporate boards employment
More informationAsthma. - A chronic inflammatory disorder which causes recurrent episodes of wheezing, breathlessness, cough and chest tightness.
Obstructive diseases Asthma - A chronic inflammatory disorder which causes recurrent episodes of wheezing, breathlessness, cough and chest tightness. - Characterized by Intermittent and reversible (the
More informationPharmacotherapy for Allergic Rhinitis
Pharmacotherapy for Allergic Rhinitis William Reisacher, MD FACS FAAOA Assistant Professor Weill Cornell Medical College The Impact of Allergic Rhinitis Allergic rhinitis affects approximately 50 million
More informationPokharel S 1, Shah DN 2, Choudhary M 3 1 Lecturer Ophthalmology Department, KMC, Sinamangal, 2 Professor and 3 Lecturer, Ophthalmology Department,
Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 526-530 Original Article Vernal keratoconjunctivitis: Modes of presentation in Nepalese population Pokharel S 1, Shah DN 2, Choudhary
More informationPredisposing factors. Gender. Ocular Surface Inflammation and Infection Control. Ocular Surface Disease 8/7/12. Ocular Surface Disease Health
Ocular Surface Inflammation and Infection Control Paul M. Karpecki, OD, FAAO Corneal Services and Ocular Disease Research Director, Koffler Vision Group - Lexington, KY Ocular Surface Disease Health! Discuss
More informationHow immunology informs the design of immunotherapeutics.
How immunology informs the design of immunotherapeutics. Stephen R Durham Allergy and Clinical Immunology, Royal Brompton Hospital and Imperial College London WAO Cancun Mon Dec 5 th 2011 How immunology
More informationINNATE IMMUNITY Non-Specific Immune Response. Physiology Unit 3
INNATE IMMUNITY Non-Specific Immune Response Physiology Unit 3 Protection Against Infection The body has several defenses to protect itself from getting an infection Skin Mucus membranes Serous membranes
More informationDRY EYE INFORMATION AND TREATMENTS
DRY EYE INFORMATION AND TREATMENTS If you cannot come to your appointment, please call us at least 24 hours before at 450.419.6345. Failure to notify us will result in a $50 fee being charged. Institut
More informationRe-submission. Scottish Medicines Consortium. Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd
Scottish Medicines Consortium Re-submission Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd 9 December 2005 The Scottish Medicines Consortium (SMC) has completed
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION
NEW ZEALAND DATA SHEET 1. PRODUCT NAME LOMIDE TM Lodoxamide trometamol 0.1% Eye Drops 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Lomide Eye Drops contains the active ingredient lodoxamide trometamol
More informationTOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%)
Published on: 23 Sep 2014 TOBAFLAM Eye Drops (Loteprednol etabonate 0.5% + Tobramycin 0.3%) Composition Loteprednol Etabonate 5 mg (0.5% w/v) Tobramycin...3 mg (0.3% w/v) Benzalkonium Chloride.. 0.01%
More informationCase no.4. Subjective. Subjective (2) Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition.
Case no.4 Contact lenses: cause Subjective Caucasian female, 62 Y.O., consulting for a XXX opinion on her condition. Works as a lab technician for a veterenary surgeon No exposure to chemicals Had been
More informationIntroduction. Allergic Rhinitis. Seventh Pediatric Asthma Education Conference 5/9/2018
It Is All One Airway Or How Allergic Rhinitis and Its Management can Affect Asthmatic Patients Stacy Dorris, MD Allergy/Immunology Vanderbilt Medical Center May 9, 2018 Introduction Allergic Rhinitis Allergic
More informationThe Effects of Systemic Medication on Ocular Allergic Disease
The Effects of Systemic Medication on Ocular Allergic Disease Gregg J. Berdy, MD, FACS Clinical Instructor in Ophthalmology, Washington University School of Medicine Key words: ocular allergic disease
More informationProperty of Presenter
Have We Missed A Role For Neutrophils In Asthma? In Steroid-Refractory Asthma? Erwin W. Gelfand, MD Chairman, Department of Pediatrics National Jewish Health Professor of Pediatrics and Immunology University
More informationEICOSANOID METABOLISM
1 EICOSANOID METABOLISM EICOSANOIDS C20 polyunsaturated fatty acids e.g. Arachidonic acid Eicosanoids physiologically, pathologically and pharmacologically active compounds PG Prostaglandins TX - Thromboxanes
More informationa.superficial (adenoid layer).contain lymphoid tissue.
Conjunctiva Dr. saifalshamarti Anatomy Microscopic: 1.Epithelium (non keratinized,includes goblet cell). 2.Epithelial basement membrane. 3.Stroma : a.superficial (adenoid layer).contain lymphoid tissue.
More informationINDICATIONS ACULAR 0,4% ophthalmic solution is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.
Page 1 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME (and dosage form) ACULAR 0,4% COMPOSITION ACULAR 0,4% ophthalmic solution contains: Ketorolac tromethamine: 4 mg/ml Preservative: Benzalkonium chloride
More informationFoundations in Microbiology Seventh Edition
Lecture PowerPoint to accompany Foundations in Microbiology Seventh Edition Talaro Chapter 16 To run the animations you must be in Slideshow View. Use the buttons on the animation to play, pause, and turn
More informationAnti-allergic ophthalmic drugs in general practice: which, why and when?
Anti-allergic ophthalmic drugs in general practice: which, why and when? Abstract Mohamed N, MBChB, FC Ophth(SA), Registrar; Smit DP, MBChB, MMed(Ophth), FCOphth(SA), Consultant Division of Ophthalmology,
More informationDr.Sushil Kumar Tripathi
Rabamipide:360 Benefits in Dry eye syndrome Dr.Sushil Kumar Tripathi Prevalence of Dry Eye Syndrome: vone in four patients attending ophthalmic clinics report symptoms of dry eye. vprevalence of dry eye
More informationDoes in-office manual expression for Meibomian Gland Dysfunction (MGD) work?
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/282816021 Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Conference
More informationDry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402
Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D. 1409 Kensington Blvd. Bowling Green, OH 43402 Summary As our understanding of dry eye disease has evolved, so
More informationHashem Al-Dujaily Abdul Aziz ALShamali Abdul Aziz ALShamali Mousa Al-Abbadi
8 Hashem Al-Dujaily Abdul Aziz ALShamali Abdul Aziz ALShamali Mousa Al-Abbadi Mediators of Inflammation The mediators of inflammation are the substances that initiate and regulate inflammatory reactions.
More informationBill Kilgore, LDO,NCLE,COA Virginia Mason Medical Center
Bill Kilgore, LDO,NCLE,COA Virginia Mason Medical Center bkilgore@specialcontactfits.com NONE Five Primary Categories of Contact Lens Complications Eyelids Tear Film Conjunctiva/Limbus Cornea Other Hypoxia:
More informationLESSONS TAUGHT IN OPTOMETRY SCHOOL IN 1982 STEROIDS KILL USE STEROIDS AND DIE USE STEROIDS AND AN IMPORTANT PART OF YOUR BODY WILL FALL OFF.???
DO YOU WANT STEROIDS Bruce E. Onofrey, OD, RPh, FAAO Professor, U. Houston University Eye Institute LESSONS TAUGHT IN OPTOMETRY SCHOOL IN 1982 STEROIDS KILL USE STEROIDS AND DIE USE STEROIDS AND AN IMPORTANT
More informationDo You See What I See (or Don t)? Office-based Ophthalmology for the Primary Care Provider
Do You See What I See (or Don t)? Office-based Ophthalmology for the Primary Care Provider Steve Roberts, MDCM, FRCSC, D. ABO 2017 PEIP Conference DoubleTree Hotel, West Edmonton Oct. 22, 2017 Faculty/Presenter
More informationAllergen Exposure and Asthma in US Inner-cities
Allergen Exposure and Asthma in US Inner-cities Elizabeth C. Matsui, MD MHS Assistant Professor of Pediatrics Division of Allergy and Immunology Johns Hopkins University May 18, 2006 Pathophysiology of
More informationNo Conflict of Interest to Report Charles Stockwell, O.D
OH MY!!! DRY EYE!!! No Conflict of Interest to Report Charles Stockwell, O.D Charles.stockwell@ttuhsc.edu The Problem 1 Filamentary Keratitis Keratoconjunctivitis sicca, or dry eye syndrome, is the most
More informationEosinophil activation in Aspirin Exacerbated Respiratory Disease (AERD)
WAC2011, Dec 7, 2011 Cancun, Mexico Eosinophil activation in Aspirin Exacerbated Respiratory Disease (AERD) Hae- Sim Park, MD, Ph D Department of Allergy & Clinical Immunology Ajou University School of
More informationStrategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH
Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH 43402 brujic@prodigy.net 419-261-9161 Summary As optometry s scope of practice continues
More informationReceived: / Revised Accepted: / Published:
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Available online at: http://www.wjpsonline.org/ Original Article Safety and Efficacy of the combination of Naphazoline
More informationAnterior Segment Cataract Surgery
Current Use of Non-steroidal Anti-inflammatory Drugs in the Treatment of Ocular Inflammation Related to Cataract Surgery Eric Donnenfeld Clinical Professor of Ophthalmology, New York University, New York,
More informationSafety, PK and PD of ARRY-502, a CRTh2 Antagonist, in Healthy Subjects with a History of Seasonal Allergies
Safety, PK and PD of ARRY502, a CRTh2 Antagonist, in Healthy Subjects with a History of Seasonal Allergies L. Burgess*, L. Anderson, C. Nugent, N. Klopfenstein, C. Eberhardt, L. Carter, C. Kass, S. RojasCaro,
More informationAllergic Eye Disease: Pathophysiology, Clinical Manifestations and Treatment
Allergic Eye Disease: Pathophysiology, Clinical Manifestations and Treatment 14 Bita Manzouri, Thomas Flynn, Santa Jeremy Ono Core Messages Allergic eye disease affects a reported 20% of the population
More informationAllergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
More informationAllergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
More informationADVANCED OPTOMETRIC PROCEDURES
ADVANCED OPTOMETRIC PROCEDURES Disclosures Dr. Nathan Lighthizer, OD, FAAO Dr. Aaron McNulty, OD, FAAO Course Outline Allergy testing Corneal collagen crosslinking Intense pulsed light therapy Epithelial
More informationThe allergic eye. Abstract. Introduction. Types of allergic conjunctivitis. Non-severe allergic conjunctivitis:
The allergic eye Andre Marais Senior lecturer and Clinical Pharmacologist Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa Correspondence
More information